Literature DB >> 11030491

Polypharmacy of 2 atypical antipsychotics.

E Rhoads.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11030491     DOI： 10.4088/jcp.v61n0914e

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  4 in total

1.  Augmentation of olanzapine in treatment-resistant schizophrenia.

Authors:  Mathias Zink
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

Review 2.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  [Augmenting atypical antipsychotic medications with clozapin].

Authors:  M Zink; H Dressing
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

4.  Antipsychotics prescribing patterns of patients with schizophrenia admitted to korean general hospital psychiatric unit: 2001 to 2008.

Authors:  Hye Jin Choi; Seung Ho Jung; Min Hee Kang; Jeong Seop Lee; Jae Nam Bae; Chul Eung Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.